TFFP: TFF Pharmaceuticals Inc. Forvard P/S multiplikatori
TFF Pharmaceuticals laboratoriyasining kukunni muzlatish quvvatlari hamkorlar uchun maksimal samaradorlikda ishlamoqda. Emitentning GURU.Markets kunlik grafigidagi kelajakdagi P/S ko'rsatkichi bozor kutganlarini aniq namoyish etmoqda, bunda 22.30 darajasi joriy holatni aks ettiradi. Biroq, yupqa plyonka texnologiyalarining sekin joriy etilishi kapitalizatsiyani cheklamoqda, likvidlik tanqisligi va Big Pharma ga bo'lgan bog'liqlik esa listingdan chiqarilishning jiddiy xavflarini yuzaga keltirmoqda.
TFF Pharmaceuticals, Inc (TFFP) moliyaviy va bozor koʻrsatkichlari kesimi
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi haqida ma'lumot:
- emitentning balans qiymati statistikasi:
- qarz yuki va likvidlik ko'rsatkichlari:
Qarzning xususiy kapitalga nisbati TFF Pharmaceuticals|TFFP - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati TFF Pharmaceuticals|TFFP - Jamlangan qarz majburiyatlari|Balans kapitallashuviga qarzlar TFF Pharmaceuticals, Inc|TFFP - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzi TFF Pharmaceuticals|Tezkor likvidlik tffpharma.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
TFFP - Sof daromad|Prognoz qilingan kelajakdagi foyda TFF Pharmaceuticals|TFFP - P/E multiplikatori|Forvard P/E multiplikatori TFF Pharma|TFFP - Narx-foyda va o‘sish multiplikatori|EV/EBITDA multiplikatori TFF Pharmaceuticals, Inc|TFFP - Foizlar, soliqlar va eskirishdan oldingi foyda|So'nggi 12 oy davomida bir aksiya uchun sof foyda TFF Pharmaceuticals|TFFP - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi 12 oy davomida bir aksiya uchun sof foydaning yillik o'sishi tffpharma.com|TFFP - Joriy yil uchun bitta aksiya uchun sof foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi TFF Pharmaceuticals
- sotuv hajmi va tushum haqida ma'lumot:
Kompaniyaning jamlanma tahlili:TFF Pharmaceuticals, Inc. TFFP
Yupqa plyonkalar orqali dori vositalarini yetkazib berish tizimini kengaytirayotgan TFF Pharmaceuticals (TFFP) uchun ushbu ko'rsatkich biznesning uzoq muddatli qiymatini kutilayotgan daromad oqimlari bilan nisbatda aks ettiradi. Bashorat qilingan P/S koeffitsiyentini tahlil qilish orqali investor bozor kapitalizatsiyasini inhalatsion dori vositalari nishasidagi kelajakdagi savdolar prizmasidan baholaydi, bu esa tendentsiya o'zgarishlarini o'z vaqtida aniqlash va turg'unlik davrlarida kapitalni qadrsizlanishdan himoya qilish imkonini beradi.
TFF Pharmaceuticals raqobatchilari
Haleon - Forvard narx/daromad multiplikatori|Narxning kutilayotgan daromadga nisbati KVUE (Kenvue Inc)|Verona Pharma Corp - Forvard P/S multiplikatori|Kelajakdagi narxning daromadga nisbati MENS|LGND: Forvard P/S multiplikatori|Kelajakdagi narxning daromadga nisbati AMRX (amneal.com)|Forvard narx/daromad multiplikatori PRGO|ALVO: Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Liquidia Technologies (LQDA)|GLPG: Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori ANIP (ANI Pharmaceuticals)|Sotuvga nisbatan forvard narx MNKD|Amphastar Pharmaceuticals, Inc. - Forvard P/S multiplikatori|PCRX - Forvard P/S multiplikatori|ARS Pharma (SPRY) - Narxning prognoz qilingan daromadga nisbati|Theravance Corp - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Aquestive Therapeutics|Forvard narx/daromad multiplikatori scPharma (SCPH)|Forvard P/S multiplikatori TECX|Forvard P/S multiplikatori Tonix Pharma (TNXP)|Forvard P/S multiplikatori SXTC (China SXT Pharmaceuticals, Inc.)|EPRX - Forvard narx/daromad multiplikatori|BioHarvest Sciences - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati invizyne.com|ORMP (oramed.com) - Forvard narx/daromad multiplikatori|Entera Bio (ENTX) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori HYFT|ABVC (ABVC BioPharma, Inc) - Narxning kutilayotgan daromadga nisbati|Forvard P/S multiplikatori CPIX|Kapitalizatsiyaning kutilayotgan sotuvga nisbati quantumbiopharma.com|Forvard P/S multiplikatori FGEN (FibroGen)|TELO - Forvard narx/daromad multiplikatori|Rani Therapeutics Inc - Forvard P/S multiplikatori|SNYR - Forvard P/S multiplikatori|rallybio.com (RLYB) - Narxning prognoz qilingan daromadga nisbati|LEXX (Lexaria Bioscience Corp.) - Narxning prognoz qilingan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Pulmatrix|Pheton (PTHL) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard narx/daromad multiplikatori APM (Aptorum Group Limited)|Narxning kutilayotgan daromadga nisbati LYRA|Forvard P/S multiplikatori IBO (Impact BioMedical Inc)|TNFA (TNF Pharmaceuticals Inc.) - Kelajakdagi narxning daromadga nisbati|cbdMD Corp - Forvard P/S multiplikatori|Kelajakdagi narxning daromadga nisbati PRFX|altamiratherapeutics.com (CYTO) - Narxning prognoz qilingan daromadga nisbati|Kelajakdagi narxning daromadga nisbati LIPO (Lipella Pharma)|Narxning prognoz qilingan daromadga nisbati OptiNose, Inc.|pieris.com - Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori PROC|PTPI (Petros Pharmaceuticals Inc) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori QLI (Qilian International Holding Group Limited)|Forvard P/S multiplikatori ACELYRIN Inc. SLRN
